04:34 PM EST, 02/19/2025 (MT Newswires) -- Daniel J. Brennan, Executive Vice President and CFO, on February 18, 2025, sold 84,863 shares in Boston Scientific ( BSX ) for $8,919,296. Following the Form 4 filing with the SEC, Brennan has control over a total of 225,808 common shares of the company, with 225,808 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885725/000122520825001969/xslF345X05/doc4.xml